# Brotizolam Tablets 0.25mg (ブロチゾラム０．２５ｍｇ錠)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 1124009F1010). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 1124009F1010
- **Product name (Japanese):** ブロチゾラム０．２５ｍｇ錠
- **English title:** Brotizolam Tablets 0.25mg
- **Active ingredient:** ブロチゾラム
- **Active ingredient (INN):** Brotizolam
- **Strength / unit:** ０．２５ｍｇ１錠
- **Route:** Oral (内用薬)
- **Therapeutic category:** 11 Central nervous system agents (中枢神経系用薬) › 112 Hypnotics, sedatives and anxiolytics (催眠鎮静剤、抗不安剤)
- **Brand / generic:** Original / brand or other
- **NHI price (reference only):** JPY 10.8 per ０．２５ｍｇ１錠
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/1124009F1010
- **JSON:** https://www.nifujipharma.com/api/drugs/1124009F1010

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Brotizolam%20Tablets%200.25mg%20(%E3%83%96%E3%83%AD%E3%83%81%E3%82%BE%E3%83%A9%E3%83%A0%EF%BC%90%EF%BC%8E%EF%BC%92%EF%BC%95%EF%BD%8D%EF%BD%87%E9%8C%A0)%20%2F%20YJ%201124009F1010#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.

## Other listed products with Brotizolam

- [Brotizolam Tablets 0.25mg (レンドルミン錠０．２５ｍｇ)](https://www.nifujipharma.com/drugs/1124009F1223) — ０．２５ｍｇ１錠, Nippon Boehringer Ingelheim
- [Brotizolam Orally Disintegrating Tablets 0.25mg (ブロチゾラム０．２５ｍｇ口腔内崩壊錠)](https://www.nifujipharma.com/drugs/1124009F2017) — ０．２５ｍｇ１錠
- [Brotizolam Tablets 0.25mg (レンドルミンＤ錠０．２５ｍｇ)](https://www.nifujipharma.com/drugs/1124009F2025) — ０．２５ｍｇ１錠, Nippon Boehringer Ingelheim